Literature DB >> 16861886

A two-hit mechanism for pre-mitotic arrest of cancer cell proliferation by a polyamide-alkylator conjugate.

David Alvarez1, C James Chou, Lucia Latella, Samantha G Zeitlin, Sherman Ku, Pier Lorenzo Puri, Peter B Dervan, Joel M Gottesfeld.   

Abstract

A polyamide-chlorambucil conjugate (1R-Chl) arrests a wide range of human cancer cell lines at the G2/M phase of the cell cycle and downregulates histone H4c gene expression. However, an siRNA against H4c mRNA causes G1/S arrest. Here, we report that 1R-Chl downregulates H4c prior to G2/M arrest. G2/M arrest is the result of extensive DNA damage by 1R-Chl, which leads to phosphorylation of H2A.X at serine 139, recruitment of the Nbs1 repair protein, and a cascade of unknown events culminating with cdc2 phosphorylation at tyrosine 15 and abolishment of cdc2 kinase activity. A control polyamide-Chl conjugate, which neither binds to the H4c gene nor has an anti-proliferative effect by itself, causes G2/M arrest when cells are treated with siRNAs specific for H3 or H4c.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861886     DOI: 10.4161/cc.5.14.2913

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

1.  Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.

Authors:  Sofia R Gameiro; Jorge A Caballero; James W Hodge
Journal:  Cancer Biother Radiopharm       Date:  2012-02-08       Impact factor: 3.099

2.  IL-17-driven intestinal fibrosis is inhibited by Itch-mediated ubiquitination of HIC-5.

Authors:  J Paul; A K Singh; M Kathania; T L Elviche; M Zeng; V Basrur; A L Theiss; K Venuprasad
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

3.  Chromatin structure determines accessibility of a hairpin polyamide-chlorambucil conjugate at histone H4 genes in pancreatic cancer cells.

Authors:  Christine Jespersen; Elisabetta Soragni; C James Chou; Paramjit S Arora; Peter B Dervan; Joel M Gottesfeld
Journal:  Bioorg Med Chem Lett       Date:  2012-04-25       Impact factor: 2.823

4.  Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia.

Authors:  C James Chou; Michelle E Farkas; Sherry M Tsai; David Alvarez; Peter B Dervan; Joel M Gottesfeld
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

5.  Mixed up minor groove binders: Convincing A·T specific compounds to recognize a G·C base pair.

Authors:  Ananya Paul; Rupesh Nanjunda; Arvind Kumar; Sarah Laughlin; Raja Nhili; Sabine Depauw; Shelby Sheldon Deuser; Yun Chai; Arpana S Chaudhary; Marie-Hélène David-Cordonnier; David W Boykin; W David Wilson
Journal:  Bioorg Med Chem Lett       Date:  2015-05-19       Impact factor: 2.823

6.  HMGA1 levels influence mitochondrial function and mitochondrial DNA repair efficiency.

Authors:  Li Mao; Kelsey J Wertzler; Scott C Maloney; Zeping Wang; Nancy S Magnuson; Raymond Reeves
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

Review 7.  Programmable DNA-binding small molecules.

Authors:  Meghan S Blackledge; Christian Melander
Journal:  Bioorg Med Chem       Date:  2013-04-18       Impact factor: 3.641

8.  Alpha-diaminobutyric acid-linked hairpin polyamides.

Authors:  Michelle E Farkas; Sherry M Tsai; Peter B Dervan
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

9.  Unanticipated differences between alpha- and gamma-diaminobutyric acid-linked hairpin polyamide-alkylator conjugates.

Authors:  Sherry M Tsai; Michelle E Farkas; C James Chou; Joel M Gottesfeld; Peter B Dervan
Journal:  Nucleic Acids Res       Date:  2006-12-14       Impact factor: 16.971

10.  Sequence-specific DNA cleavage mediated by bipyridine polyamide conjugates.

Authors:  Philippe Simon; Fabio Cannata; Loïc Perrouault; Ludovic Halby; Jean-Paul Concordet; Alexandre Boutorine; Vladimir Ryabinin; Alexandre Sinyakov; Carine Giovannangeli
Journal:  Nucleic Acids Res       Date:  2008-05-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.